Jonathan Violin Net Worth

Jonathan Violin biography

Jonathan Violin Ph.D. serves as President, Chief Operating Officer of the Company. Prior to becoming President, Dr. Violin co-founded Viridian and led its operations since its founding in 2020. Prior to co-founding Viridian, Dr. Violin served as founding CEO of two virtual drug discovery companies, Quellis Biosciences Inc. (“Quellis”), and Dianthus Therapeutics, Inc. (“Dianthus”), which were founded in November 2017 and May 2019, respectively. Previously, Dr. Violin co-founded and helped lead Trevena Inc. from discovery research through clinical development and NDA submission, including multiple rounds of venture and public financing. While at Trevena from 2008 to 2018, Dr. Violin’s leadership roles included discovery biology, investor relations, corporate strategy, and scientific affairs. Dr. Violin holds a Ph.D. from the Department of Pharmacology at the University of California, San Diego, an Master of Business Administration with a concentration in Health Sector Management from the Fuqua School of Business, and a Bachelor of Sciences in Chemical Pharmacology from Duke University.

How old is Jonathan Violin?

Jonathan Violin is 44, he's been the President and Chief Operating Officer of Miragen Therapeutics Inc since 2020. There are 7 older and 2 younger executives at Miragen Therapeutics Inc. The oldest executive at Miragen Therapeutics Inc is Arlene Morris, 68, who is the Independent Director.

What's Jonathan Violin's mailing address?

Jonathan's mailing address filed with the SEC is 955 Chesterbrook Blvd Suite 200, Chesterbrook, PA 19087, USA.

Insiders trading at Miragen Therapeutics Inc

Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth, and Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.

What does Miragen Therapeutics Inc do?

Miragen Therapeutics Inc executives and stock owners

Miragen Therapeutics Inc executives and other stock owners filed with the SEC include:

• Diana Escolar,
  Chief Medical Officer
• Jason Leverone,
  Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary
• Jeffrey Hatfield,
  Independent Chairman of the Board
• Joseph Turner,
  Independent Director
• Arlene Morris,
  Independent Director
• Christopher Bowden,
  Independent Director
• Tomas Kiselak,
  Director
• Peter Harwin,
  Director
• Lee Rauch,
  Chief Executive Officer, Director
• Jonathan Violin,
  President, Chief Operating Officer
• Bruce Booth,
  Director
• Kyle Lefkoff,
  Director
• Paul D Rubin,
  EVP, Research & Development
• Adam Scott Levy,
  Chief Business Officer
• Thomas E. Hughes,
  Director
• Bennett S Lebow,
  Director
• Global Master Fund Lp Logos,
  10% owner
• John W Creecy,
  Director
• Kevin Koch,
  Director
• Funds Management Llc Fairmo...,
  
• William Stuart Marshall,